Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

PubWeight™: 1.82‹?› | Rank: Top 3%

🔗 View Article (PMID 10649244)

Published in Cancer on February 01, 2000

Authors

J W Marsh1, I Dvorchik, C A Bonham, S Iwatsuki

Author Affiliations

1: Department of Surgery, Thomas E. Starzl Transplantation Institute, Falk Clinic, Pittsburgh, PA 15213, USA.

Articles citing this

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology (2008) 6.15

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut (2002) 1.66

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg (2004) 1.59

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut (2005) 1.54

Liver transplantation for hepatocellular carcinoma. Ann Surg (2001) 1.46

Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36

Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (2000) 1.33

The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg (2004) 1.14

Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol (2007) 0.97

Staging of hepatocellular carcinoma. J Clin Exp Hepatol (2014) 0.97

Moving toward an understanding of the metastatic process in hepatocellular carcinoma. World J Gastroenterol (2001) 0.96

Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J Gastroenterol (2006) 0.95

Clinical significance of surgical resection of metastatic lymph nodes from hepatocellular carcinoma. Surg Today (2014) 0.94

Hepatocellular Carcinoma and Liver Transplantation: State of the Art. J Clin Transl Hepatol (2014) 0.90

Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology (2001) 0.90

Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm. World J Surg (2008) 0.90

The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Dig Dis Sci (2008) 0.89

Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol (2009) 0.88

Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J Gastrointest Surg (2007) 0.88

Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma. World J Gastroenterol (2008) 0.87

Obesity and microvascular invasion in hepatocellular carcinoma. Cancer Invest (2010) 0.85

Milan Criteria and UCSF Criteria: A Preliminary Comparative Study of Liver Transplantation Outcomes in the United States. Int J Hepatol (2012) 0.84

Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT). Cancer Imaging (2005) 0.83

ZIP4, a novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation. Int J Biol Sci (2014) 0.81

Role of liver transplantation for hepatocellular carcinoma. J Clin Exp Hepatol (2014) 0.80

The role of bridging therapy in hepatocellular carcinoma. Int J Hepatol (2013) 0.79

Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation? HPB (Oxford) (2012) 0.79

Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol (2006) 0.77

Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77

Liver transplantation for hepatocellular carcinoma exceeding the Milan criteria: a single-center experience. J Cancer Res Clin Oncol (2013) 0.76

A mathematical model for optimizing the indications of liver transplantation in patients with hepatocellular carcinoma. Theor Biol Med Model (2013) 0.75

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review. World J Gastroenterol (2016) 0.75

Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison. World J Gastroenterol (2014) 0.75

Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation. Hepatobiliary Surg Nutr (2016) 0.75

Liver transplantation for hepatocellular carcinoma: a single European centre experience. Langenbecks Arch Surg (2004) 0.75

Overexpression of CD147 is associated with poor prognosis, tumor cell migration and ERK signaling pathway activation in hepatocellular carcinoma. Exp Ther Med (2017) 0.75

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

Experience with 150 liver resections. Ann Surg (1983) 3.01

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Liver transplantation in adults. Hepatology (1982) 2.89

Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80

Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80

Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet (1985) 2.59

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48

Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids. Surg Gynecol Obstet (1982) 2.42

Liver transplantation across ABO blood groups. Surgery (1986) 2.39

The antibody crossmatch in liver transplantation. Surgery (1986) 2.33

The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32

Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22

Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol (1988) 2.21

Left hepatic trisegmentectomy. Surg Gynecol Obstet (1982) 2.16

Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis (1985) 2.16

A growth factor in fine vascular anastomoses. Surg Gynecol Obstet (1984) 2.15

Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11

Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07

Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics (1986) 2.04

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg (1998) 1.99

Biliary Excretion of Cyclosporine in Liver Transplant Patients. Transplant Proc (1985) 1.98

Liver transplantation against T cell-positive warm crossmatches. Transplant Proc (1984) 1.96

Liver resection for metastatic colorectal cancer. Surgery (1986) 1.92

Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89

Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics (1984) 1.86

Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med (1973) 1.85

Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg (1982) 1.84

Corrective treatment and anatomic considerations for laparoscopic cholecystectomy injuries. J Am Coll Surg (1994) 1.81

Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80

Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc (1991) 1.77

Current status of hepatic transplantation. Semin Liver Dis (1983) 1.75

Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74

Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc (1973) 1.73

Retransplantation of the liver. Semin Liver Dis (1985) 1.73

Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg (1998) 1.72

Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med (1980) 1.69

Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer (1991) 1.68

Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol (1986) 1.63

Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis (1985) 1.62

Liver transplantation: an unfinished product. Transplant Proc (1989) 1.61

Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: an initial report. J Surg Res (1978) 1.60

Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant (2009) 1.59

Liver transplantation for fulminant hepatic failure. Semin Liver Dis (1985) 1.56

Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients. Transplant Proc (1985) 1.55

Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr (1982) 1.54

Should hepatomas be treated with hepatic resection or transplantation? Cancer (1999) 1.54

Cholangiography and interventional biliary radiology in adult liver transplantation. AJR Am J Roentgenol (1985) 1.54

Angiography of liver transplantation patients. Radiology (1985) 1.53

Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology (1987) 1.53

Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol (1996) 1.53

Medical aspects of liver transplantation. Hepatology (1984) 1.52

Cyclosporine monitoring in liver transplant patients. Transplantation (1985) 1.51

Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50

An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48

Indications for liver transplantation in the cyclosporine era. Surg Clin North Am (1986) 1.46

Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer (1992) 1.45

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation (1981) 1.38

Excisional treatment of cavernous hemangioma of the liver. Ann Surg (1980) 1.37

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology (1997) 1.36

Orthotopic Liver Transplantation in Children With Hepatic-Based Metabolic Disease. Transplant Proc (1983) 1.36

The incidence of portal vein thrombosis at liver transplantation. Hepatology (1992) 1.35

OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc (1987) 1.35

Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (2000) 1.33

Linear growth following pediatric liver transplantation. Am J Dis Child (1987) 1.33

Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr (1985) 1.32

De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30